|
JRC Publications Repository >
Browsing by Author MORGENSTERN Alfred
Showing results 21 to 40 of 92
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type | | 2008 | The Cytokinesis-Block Micronucleus Assay as a Biological Dosimeter for Targeted Alpha Therapy | SONG E.; RIZVI S.; QU C. F.; RAJA C.; YUEN J.; LI Y.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J. | Articles in Journals |
| 2006 | Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and Clusters | SONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J. | Articles in Journals |
| 2013 | Decay data measurements on 213Bi using recoil atoms | MAROULI MARIA; SULIMAN GABRIEL; POMME Stefaan; VAN AMMEL Raf; JOBBAGY VIKTOR; STROH HEIKO; DIKMEN H.; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank, et al | Articles in Journals |
| 2008 | Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian Cancer | KNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C. | Articles in Journals |
| 2012 | Die intravesikale Radioimmuntherapie mit Bi-213-anti-EGFR Immunkonjugaten verursacht keine Schäden am Urothel | MÜLLER Felix; SEIDL C.; WEIRICH G; RÖTZER S; FAZEL J; FRANK Annette; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2012 | DTPA complexation of bismuth in human blood serum | MONTAVON Gilles; LE DU Alicia; CHAMPION J; RABUNG T.; MORGENSTERN Alfred | Articles in Journals |
| 2012 | Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest | VALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank, et al | Articles in Journals |
| 2009 | Evidence of Extranuclear Cell Sensitivity to Alpha-particle Radiation Using a Microdosimetric Model - I - Presentation and Validation of a Microdosimetric Model | CHOUIN N; BERNARDEAU K; DAVODEAU F; CHÉREL M; FAIVRE-CHAUVET A; BOURGEOIS M; APOSTOLIDIS Christos; MORGENSTERN Alfred; LISBONA A; BARDIÈS M | Articles in Journals |
| 2009 | Evidence of Extranuclear Cell Sensitivity to Alpha-Particle Radiation Using a Microdosimetric Model - II - Application of the Microdosimetric
Model to Experimental Results | CHOUIN N; BERNARDEAU K; BARDIÈS M; FAIVRE-CHAUVET A; BOURGEOIS M; APOSTOLIDIS Christos; MORGENSTERN Alfred; LISBONA A; CHÉREL M; DAVODEAU F. | Articles in Journals |
| 2012 | Feasibility of 99Mo production by proton-induced fission of 232Th | ABBAS Kamel; HOLZWARTH Uwe; SIMONELLI Federica; KOZEMPEL JAN; CYDZIK Izabela; BULGHERONI A.; COTOGNO Giulio; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; MORGENSTERN Alfred | Articles in Journals |
| 2010 | A feasibility study of a new method for production of U-230/TH-226 fro alpha-immunotherapy applications | ABBAS Kamel; SIMONELLI Federica; CYDZIK Izabela; KOZEMPEL JAN; APOSTOLIDIS Christos; ZIELINSKA Barbara; BRUCHERTSEIFER Frank; MORGENSTERN Alfred | Contributions to Conferences |
| 2005 | Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse Type Gastric Cancer Using A 213BI-conjugated Monoclonal Antibody | BLOECHEL S.; BECK R.; SEIDL C.; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2007 | Gemcitabine Radiosensitizes Multiple Myeloma Cells to Low LET, but not High LET, Irradiation | SUPIOT S.; THILLAYS F.; RIO E.; GOUARD S.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; MAHE M. A.; CHATAL J. F.; DAVODEAU F.; CHEREL M. | Articles in Journals |
| 2013 | Half-lives of 221Fr, 217At, 213Bi, 213Po and 209Pb from the 225Ac decay series | SULIMAN GABRIEL; POMME Stefaan; MAROULI Maria; VAN AMMEL Raf; STROH HEIKO; JOBBAGY Viktor; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos, et al | Articles in Journals |
| 2012 | High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum | RAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2012 | High-resolution alpha-particle spectrometry of the 230U decay series | MAROULI MARIA; POMME Stefaan; PAEPEN Jan; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN ABDULLAH; SULIMAN GABRIEL; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel, et al | Contributions to Conferences |
| 2010 | Immunoliposomal Delivery of 213Bi for Alpha-emitter Targeting of Metastatic Breast Cancer | LINGAPPA M.; SONG H.; THOMPSON S.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SGOUROS G. | Articles in Journals |
| 2007 | An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha Therapy | ZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED | Articles in Journals |
| 2009 | In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapy | BRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS Christos | Contributions to Conferences |
| 2012 | In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapy | GRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER Matthias | Contributions to Conferences |
Showing results 21 to 40 of 92
|
